DaVita Inc. (NYSE:DVA) Shares Acquired by CIBC Asset Management Inc

CIBC Asset Management Inc raised its holdings in shares of DaVita Inc. (NYSE:DVA) by 1.4% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 7,730 shares of the company’s stock after purchasing an additional 109 shares during the quarter. CIBC Asset Management Inc’s holdings in DaVita were worth $1,156,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Transcendent Capital Group LLC acquired a new position in shares of DaVita in the 3rd quarter worth approximately $25,000. Blue Trust Inc. grew its position in shares of DaVita by 56.4% in the 3rd quarter. Blue Trust Inc. now owns 330 shares of the company’s stock worth $54,000 after acquiring an additional 119 shares in the last quarter. Quarry LP acquired a new position in shares of DaVita in the 3rd quarter worth approximately $60,000. Versant Capital Management Inc grew its position in shares of DaVita by 58.7% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $68,000 after acquiring an additional 169 shares in the last quarter. Finally, Wingate Wealth Advisors Inc. acquired a new position in shares of DaVita in the 4th quarter worth approximately $82,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

DaVita Trading Down 2.5 %

Shares of NYSE DVA opened at $142.33 on Friday. The stock’s 50 day simple moving average is $161.03 and its 200 day simple moving average is $158.00. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. The company has a market cap of $11.39 billion, a price-to-earnings ratio of 13.25, a price-to-earnings-growth ratio of 1.07 and a beta of 0.94. DaVita Inc. has a 12-month low of $120.78 and a 12-month high of $179.60.

DaVita (NYSE:DVA) last announced its earnings results on Thursday, February 13th. The company reported $2.24 earnings per share for the quarter, beating the consensus estimate of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. Equities research analysts expect that DaVita Inc. will post 10.76 EPS for the current year.

Analyst Upgrades and Downgrades

DVA has been the topic of several recent research reports. Cowen reissued a “hold” rating on shares of DaVita in a report on Tuesday. Barclays raised their price target on DaVita from $164.00 to $169.00 and gave the stock an “equal weight” rating in a report on Tuesday, February 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, DaVita presently has an average rating of “Hold” and an average target price of $162.80.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.